The textbook on lung cancer: time for personalized medicine

被引:0
|
作者
不详
机构
关键词
D O I
10.3978/j.issn.2072-1439.2015.04.43
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:E107 / E111
页数:5
相关论文
共 50 条
  • [21] A Personalized Medicine Approach to Lung Cancer and Melanoma.
    Vnencak-Jones, C.
    Su, Z.
    Fohn, L.
    Coffin, C.
    Gonzalez, A.
    Itani, D.
    Shi, C.
    Sosman, J.
    Pao, W.
    MODERN PATHOLOGY, 2011, 24 : 447A - 447A
  • [22] Personalized medicine for lung cancer: new challenges for pathology
    Kerr, Keith M.
    HISTOPATHOLOGY, 2012, 60 (04) : 531 - 546
  • [23] Molecular pathology of lung cancer: key to personalized medicine
    Cheng, Liang
    Alexander, Riley E.
    MacLennan, Gregory T.
    Cummings, Oscar W.
    Montironi, Rodolfo
    Lopez-Beltran, Antonio
    Cramer, Harvey M.
    Davidson, Darrell D.
    Zhang, Shaobo
    MODERN PATHOLOGY, 2012, 25 (03) : 347 - 369
  • [24] Lung cancer trial aims to bolster personalized medicine
    Harrison, Charlotte
    NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (06) : 407 - 407
  • [26] Personalized medicine in lung cancer: what we need to know
    Tony S. K. Mok
    Nature Reviews Clinical Oncology, 2011, 8 : 661 - 668
  • [27] Personalized medicine in lung cancer: what we need to know
    Mok, Tony S. K.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (11) : 661 - 668
  • [28] Personalized medicine for non-small-cell lung cancer
    Mok, Tony S.
    Zhou, Qing
    Leung, Linda
    Loong, Herbert H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (10) : 1601 - 1611
  • [29] Lung Cancer and Personalized Medicine Current Knowledge and Therapies Preface
    Ahmad, Aamir
    Gadgeel, Shirish
    LUNG CANCER AND PERSONALIZED MEDICINE: CURRENT KNOWLEDGE AND THERAPIES, 2016, 893 : V - VI
  • [30] Personalized Medicine and Inhibition of EGFR Signaling in Lung Cancer.
    Gazdar, Adi F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10): : 1018 - 1020